STOCK TITAN

Encompass Health Corp - EHC STOCK NEWS

Welcome to our dedicated news page for Encompass Health (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Encompass Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Encompass Health's position in the market.

Rhea-AI Summary
Encompass Health Corp. appoints Andrew Baird as senior vice president of public policy, legislation, and regulations, bringing 20 years of experience to the role. Baird previously held positions at Enhabit Home Health and Hospice and Christian & Barton, LLP.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Encompass Health Corp. and Piedmont are awarded a certificate of need to build a 40-bed inpatient rehabilitation hospital in Loganville, Georgia. The hospital will offer care for patients recovering from various conditions and will feature advanced rehabilitation technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
none
-
Rhea-AI Summary
Encompass Health Corp. (EHC) will participate in the Barclays Global Healthcare Conference on March 12-14, 2024, with key executives engaging in a fireside chat. The event will be webcast live for investors and stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
conferences
Rhea-AI Summary
Encompass Health Corporation (EHC) declares a quarterly cash dividend of $0.15 per share, payable on April 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
dividends
-
Rhea-AI Summary
Encompass Health Corp. (EHC) plans to construct a 60-bed inpatient rehabilitation hospital in Avondale, Arizona, offering specialized care for patients with various conditions. The hospital will provide comprehensive therapies and advanced technologies to aid in recovery, aiming to enhance patients' quality of life and independence.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
-
Rhea-AI Summary
Encompass Health Corporation (NYSE: EHC) reported a strong finish to 2023, with a 9.6% increase in net operating revenue and a 18.5% growth in Adjusted EBITDA for the full year. The company also experienced a 103.3% surge in adjusted free cash flow. President and CEO Mark Tarr expressed optimism in the company's value proposition and operating strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
earnings
Rhea-AI Summary
Encompass Health Corp. (EHC) has been named to Fortune's 'World's Most Admired Companies' list for 2024, marking the fourth consecutive year the company has received this recognition. The collaboration with Korn Ferry involved surveying executives, directors, and analysts to rate companies on nine criteria, resulting in a total of 660 companies from 29 countries being named among the 'World's Most Admired Companies'. Encompass Health President and CEO, Mark Tarr, expressed gratitude for the recognition, emphasizing the company's commitment to providing high-quality care and expanding their presence to reach more patients and make a meaningful difference in the communities they serve.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
-
Rhea-AI Summary
Encompass Health Corp. (NYSE: EHC) will report Q4 2023 results on Feb. 7, 2024, and host an investor conference call on Feb. 8, 2024, to discuss the results. The conference call details are provided for both domestic and international callers, and a webcast and online replay will be available on the investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
earnings
-
Rhea-AI Summary
Encompass Health Corporation (EHC) appoints Edward M. Christie III to its board of directors, expanding the board to 12 seats as part of succession planning. Christie, President and CEO of Spirit Airlines, brings over two decades of finance and leadership experience in the airline industry. His appointment reflects Encompass Health's commitment to adding expertise and new perspectives for board transition while maintaining its position as a leading provider of inpatient rehabilitation services in healthcare.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
management
Rhea-AI Summary
Encompass Health (NYSE: EHC) Announces Opening of Encompass Health Rehabilitation Hospital of Fitchburg, Providing Specialized Care for Patients Recovering from Debilitating Illnesses and Injuries
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
Encompass Health Corp

NYSE:EHC

EHC Rankings

EHC Stock Data

7.78B
98.72M
1.85%
100.56%
1.99%
General Medical and Surgical Hospitals
Health Care and Social Assistance
Link
US
Birmingham

About EHC

as a national leader of post-acute care, encompass health offers facility-based and home-based patient care through our network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. we are committed to delivering high-quality, cost-effective care across the post-acute continuum. driven by a set of shared values, encompass health is the result of the union between healthsouth corporation and encompass home health & hospice.our approach to post-acute care sets us apart. we firmly believe that every success starts with our dedicated team of professionals, so we make sure they are empowered with the tools they need to help our patients be successful. innovative technologies, advanced therapies, customized treatment plans, coordinated care teams – these are all part of our promise to deliver the highest level of care.